Company news

Curis, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Curis Announces FDA Clearance of IND Application for CI-8993, the First-In-Class Monoclonal Anti-VISTA Antibody

June 9, 2020

Curis Reports First Quarter 2020 Financial Results

May 11, 2020

Curis to Release First Quarter 2020 Financial Results and Hold Conference Call on May 12, 2020

May 4, 2020

Curis Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Business Update

March 18, 2020

Curis Announces $30 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC

February 26, 2020

Curis® and DarwinHealth Announce Scientific Collaboration to Characterize Biomarkers and Tumor Subtype Alignments for Fimepinostat in DLBCL and Solid Malignancies

January 12, 2020

Curis Announces Option and License Agreement with ImmuNext for the Development and Commercialization of Anti-VISTA Antibodies

January 6, 2020

Curis Announces Positive Safety, Tolerability and Pharmacokinetic Data in Ongoing Phase 1 Study of Fimepinostat in Combination with Venetoclax

December 5, 2019

Curis Reports Third Quarter 2019 Financial Results

November 4, 2019

Curis to Release Third Quarter Financial Results and Hold Conference Call on November 5, 2019

October 28, 2019

Curis Reports Second Quarter 2019 Financial Results

August 5, 2019

Curis to Release Second Quarter Financial Results and Hold Conference Call on August 6, 2019

July 29, 2019

Curis Reports First Quarter 2019 Financial Results

May 13, 2019

Curis Completes Mesothelioma Enrollment in CA-170 Study

May 5, 2019

← Newer news releases

Calls

The 5 newest of 21 calls. Every call is listed under its year.

Decks

The 5 newest of 57 decks. Every deck is listed under its year.